Capital Contribution Transfer Tax on Equity Interests: Calculation Methods and Tax Saving Points

📖 Approx. 10 minPublished May 8, 2026

Importance of Equity Interest Transfer Taxation in Healthcare M&A

Mergers and acquisitions (M&A) of medical institutions, particularly the transfer of equity interests in medical corporations, require extremely careful consideration from a tax perspective due to their complexity and specialized nature. Correctly understanding the calculation method for capital gains tax and implementing appropriate tax-saving measures are essential for the smooth execution of M&A and for optimizing the tax burden for both transferors and transferees.

Unlike stock companies, medical corporations have a unique rights structure known as equity interests (member rights). The transfer of these equity interests differs from a simple stock transfer and tends to involve more complex tax treatment. Specifically, the valuation of equity interests is calculated considering various factors such as the net assets, profitability, and future prospects of the medical corporation, and the appropriateness of this valuation directly impacts the capital gains tax amount. Furthermore, specific considerations are required for the application of medical corporation-specific business succession tax systems, the refund of funds, and the handling of medical fee receivables.

This article focuses on the transfer of equity interests in healthcare M&A, explaining the calculation method for capital gains tax, key tax-saving points, and the unique characteristics of medical corporations that require attention, from a professional standpoint. Our aim is to provide valuable information for medical corporation directors, clinic presidents, and all those considering M&A of medical institutions.

Calculation Method for Capital Gains Tax on Equity Interest Transfers

Income arising from the transfer of equity interests is generally taxed as capital gains. The fundamental calculation for capital gains tax involves subtracting the “acquisition cost” and “transfer expenses” from the “transfer revenue amount” to arrive at the “capital gain.” However, valuing the equity interests of a medical corporation is not straightforward due to its unique nature.

1. Calculation of Transfer Revenue Amount:
This is the consideration agreed upon for the transfer of equity interests in the M&A agreement. It is crucial to accurately reflect the terms of the contract.

2. Acquisition Cost:
The acquisition cost of equity interests is generally based on the total amount of initial capital contributions and any subsequent increases in capital. However, in the case of medical corporations, factors such as past retained earnings or contributions to funds may affect the effective acquisition cost. Detailed consultation with experts is necessary to determine how these factors are valued and included in the acquisition cost.

3. Transfer Expenses:
Brokerage fees, legal fees, tax accountant fees, and registration fees incurred in executing the M&A can be added to the acquisition cost as transfer expenses.

4. Calculation of Capital Gain:

Income tax rates (including special reconstruction income tax) and resident tax rates are applied to the capital gain calculated by this formula. For individuals, capital gains are typically subject to “separate taxation,” meaning they are taxed independently of other income. However, the specific income category for the transfer of equity interests in a medical corporation may vary depending on the individual circumstances and the tax authorities’ interpretation, making prior confirmation essential.

In particular, if the valuation of the equity interests is significantly low or if non-market factors are strong, there is a risk of being deemed a “deemed transfer” by the tax authorities. This is a system where taxation is based on the fair market value as if the transfer occurred at that price, rather than the actual transfer price, potentially leading to unexpected tax liabilities.

Unique Issues and Tax Saving Points for Medical Corporations

The transfer of equity interests in medical corporations involves many unique issues that differ from those of stock companies, and understanding these is key to tax savings. Below are the main issues and tax-saving points considering them.

1. Equity Interest Valuation Methods and Appropriate Valuation

The valuation of equity interests is one of the most critical factors influencing the capital gains tax amount. Generally, it is evaluated by comprehensively considering the following factors:

• Net Asset Value: The amount remaining after deducting liabilities such as loans from assets like real estate, equipment, and deposits owned by the corporation. The difference between the market value and book value is particularly important.
• Profitability: Average earnings over the past few years (medical fees revenue, business revenue, etc.) and future earnings projections.
• Future Prospects: Position within the regional healthcare plan, competitive landscape of clinics, future prospects of medical specialties, potential for new technology adoption, etc.

These factors must be objectively and rationally calculated with reference to the National Tax Agency’s “Basic Notice on Property Valuation” and valuation methods used by experts (e.g., net asset value method, income capitalization method, progressive valuation method). Inaccurate valuations carry the risk of being flagged during tax audits.

2. Refund of Funds and Tax Treatment

In medical corporations, “funds” may have been contributed during establishment or subsequent operations. Unlike equity interests, refunds of these funds are generally not obligatory, but their nature can be a point of contention. When funds are refunded, the tax treatment can be complex, such as whether the refunded amount can be added to the acquisition cost of equity interests or if it is considered a distribution of surplus.

Generally, the refund of funds may be considered as an acquisition cost in the calculation of capital gains tax on equity interest transfers, but the requirements are strict, and confirmation by an expert for each individual case is essential.

3. Handling of Medical Fee Receivables

Medical fee receivables are important assets for medical corporations, and their collectability and valuation affect the transfer price in M&A. The valuation of outstanding medical fee receivables impacts the calculation of the transfer revenue amount, consequently affecting the capital gains tax amount. For receivables that are difficult to collect, a lower valuation may allow for appropriate adjustment of the transfer revenue amount, potentially reducing the capital gains tax burden. However, excessive undervaluation risks being questioned by tax authorities.

4. Differences Between Medical Corporation Types (Equity vs. Non-Equity Companies)

Medical corporations are broadly categorized into “equity companies,” which have equity interests owned by members that can be transferred, and “non-equity companies,” established by member contributions, where equity interests cannot be transferred or inherited. M&A targets are generally “equity companies.” For non-equity companies, succession through member changes or asset transfers of the corporation itself (business transfer) are the primary methods. The taxation of equity interest transfers is a unique issue for equity companies, and non-equity companies have different tax treatments.

5. Tax Saving Strategies for Capital Gains Tax

As a tax-saving strategy, the first step is to conduct an appropriate valuation of equity interests. By working with experts and performing valuations based on objective grounds, excessively high tax burdens can be avoided. Secondly, devising the M&A structure can be effective. For example, in addition to the direct transfer of equity interests, methods such as dissolving the medical corporation and transferring its assets (liquidation M&A) can be considered. In the case of liquidation M&A, different tax rates may apply compared to capital gains tax, potentially reducing the tax burden. Furthermore, utilizing business succession tax systems, installment payments of transfer consideration, or payments for services rendered can also lead to the equalization or reduction of tax burdens.

Healthcare-Specific Permits, Facility Standards, and Regional Healthcare Plans in M&A

In M&A of medical institutions, not only the taxation of equity interests but also healthcare industry-specific issues such as permits essential for business continuity, facility standards, and alignment with regional healthcare plans are extremely important.

1. Succession of Permits

Operating a medical corporation requires a wide range of permits, including “establishment permits” from public health centers, “designation as an insured medical institution” with the regional bureau of health and welfare, and permits based on the “Pharmaceuticals and Medical Devices Act” for pharmacies and pharmaceutical sales. These permits are generally tied to the corporate entity or individual representatives, and the succession procedures vary significantly depending on the M&A structure (equity interest transfer, business transfer, merger, etc.). Particularly in the case of equity interest transfer, since the corporate entity continues to exist, the permit succession procedures tend to proceed relatively smoothly, but confirmation that the transferee meets the requirements is essential. In the case of business transfers, re-applications or notifications are often required for individual permits, necessitating careful planning to avoid business suspension periods.

2. Facility Standards and Impact of Medical Fee Revisions

To claim medical fees, medical institutions must meet the “facility standards” set by the Ministry of Health, Labour and Welfare. These include staffing, equipment, and medical safety management systems. Whether these facility standards can be maintained or will be revised due to M&A can significantly alter future profitability. In particular, medical fee revisions occur periodically and directly impact the revenue structure of medical institutions. Due diligence (DD) in M&A must include an assessment of not only the current compliance with facility standards but also the risk of future revisions. It is important for the transferee to have a clear plan for maintaining and improving the transferor’s facility standards.

3. Consistency with Regional Healthcare Plans

The government promotes “regional healthcare plans” to ensure the provision of healthcare services in regions. These plans promote the differentiation and collaboration of hospital bed functions and integration with home care and nursing care. In M&A of medical institutions, consistency with these regional healthcare plans may be questioned. For example, in regions where bed reduction is expected in the future, acquiring a medical institution with a large number of beds requires collaboration with local governments and related organizations to ensure that the subsequent business plan is not inconsistent with the plan. The perspective of contributing to regional healthcare, not just business expansion, is also essential for smooth M&A.

4. Handling of Business Tax

Business tax for medical corporations is generally non-taxable. However, certain revenue-generating businesses (e.g., sales of pharmaceuticals and medical devices, operation of paid nursing homes) may be subject to taxation. During M&A due diligence, it is necessary to identify the existence of such revenue-generating businesses and their revenue amounts to assess future tax risks. In the case of equity interest transfers, since the corporate entity continues, the previous tax relationships are inherited. If new revenue-generating businesses are to be started in the post-M&A business plan, it is recommended to consult with experts in advance regarding the handling of business tax.

M&A and Business Succession Steps and the Importance of Utilizing Experts

M&A and business succession of medical institutions require complex procedures and specialized knowledge, making planned steps and the utilization of experts key to success. Below are the general steps and the roles of experts at each stage.

1. Consideration and Planning for M&A/Business Succession:
   Clarification of Objectives: Clearly define the M&A objectives, such as business expansion, addressing lack of successors, or contributing to regional healthcare.
   Initial Consultation: Seek initial consultations with experts such as tax accountants and M&A advisors to grasp the overall picture.
2. Target Search and Initial Negotiations:
   Candidate Search: Use M&A intermediaries and experts to find suitable counterparties.
   Execution of Non-Disclosure Agreement (NDA): Sign an NDA before exchanging information.
   Execution of Letter of Intent (LOI): Sign an LOI outlining the general terms of the transaction and granting exclusivity.
3. Due Diligence (DD):
   Formation of Expert Team: Assemble an expert team including lawyers, tax accountants, auditors, and healthcare consultants.
   Comprehensive Investigation: Conduct detailed investigations into financial, tax, legal matters, healthcare-specific permits, facility standards, and alignment with regional healthcare plans.
4. Execution of Final Agreement:
   Contract Drafting and Negotiation: Based on DD results, lawyers draft and negotiate the final sale and purchase agreement.
   Determination of Terms: Finalize the transfer price, payment method, representations and warranties, and conditions for termination.
5. Closing and Execution:
   Payment and Equity Transfer: Make the payment and transfer the equity interests according to the agreement.
   Notifications and Applications to Authorities: Complete procedures for permit succession and changes in insured medical institution designation.
6. PMI (Post Merger Integration):
   Integration Process: Execute business integration, cultural fusion, system integration, etc.
   Measurement and Improvement: Measure integration effects and implement improvement measures as needed.

Specifically, M&A of medical institutions requires a wide range of expertise, including tax (capital gains tax, business tax), legal (contracts, permits), medical practice (facility standards, medical fees), and alignment with regional healthcare plans. Therefore, forming and collaborating with an expert team, such as an M&A support organization specializing in the healthcare industry like M&A Medical, and experienced tax accountants and lawyers, is the most reliable way to minimize risks and achieve smooth and successful M&A.

M&A Medical, as an M&A support organization certified by the Small and Medium Enterprise Agency, offers consultations regarding M&A and business succession of medical institutions. We provide detailed support based on specialized knowledge and experience, covering equity interest valuation, capital gains tax calculation, tax-saving measures, M&A structuring, due diligence, and post-execution PMI. Please feel free to contact us for an initial consultation.

For Medical Succession Consultations, Contact M&A Medical

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support organization certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations facing successor shortages to strategic acquisitions on a success-fee basis.

• Initial consultation and preliminary assessment are free
• No upfront fees or monthly charges (success fee only)
• Strict confidentiality (proceeds after signing NDA)
• Support available nationwide across all 47 prefectures and all medical specialties

Please consult with us early, even in the initial stages of consideration, whether you simply want to know the market value, have no successor, or are considering joining a group.

Apply for Free Consultation